复方山莨菪碱新斯的明缓释片的制备及体外释药行为研究
x

请在关注微信后,向客服人员索取文件

篇名: 复方山莨菪碱新斯的明缓释片的制备及体外释药行为研究
TITLE:
摘要: 目的:制备复方山莨菪碱新斯的明缓释片,研究其体外释药行为。方法:以消旋山莨菪碱和甲硫酸新斯的明为主药,羟丙基甲基纤维素K4M为缓释骨架材料,硬脂酸镁为润滑剂,聚乙烯吡咯烷酮为黏合剂,预胶化淀粉为稀释剂,微晶纤维素为崩解剂和填充剂,采用湿法制粒和直接压片法制备复方山莨菪碱新斯的明缓释片,高效液相色谱法检测2个主药12 h内的体外累积释放度。结果:成功制得复方山莨菪碱新斯的明缓释片,其在12 h内体外释放基本完成,山莨菪碱累积释放度为91.3%,新斯的明累积释放度为96.5%。结论:成功制得可累积释药12 h的复方山莨菪碱新斯的明缓释片。
ABSTRACT: OBJECTIVE: To prepare the Compound anisodamine and neostigmine sustained-release tablet and study the in vitro drug release behavior. METHODS: Using raceanisodamine and neostigmine methyl sulfate as main medicines, hydroxypropyl methyl cellulose as sustained release skeleton material, magnesium stearate as the lubricant, polyvinyl pyrrolidone as the adhesive, pregelatinized starch as the thinner, microcrystalline cellulose as the disintegrant and filler, Compound anisodamine and neostigmine sustained-release tablet was prepared by wet granulation method and direct compression method. The in vitro cumulative release rate within 12 h of the 2 main medicines was detected by HPLC method. RESULTS: Compound anisodamine and neostigmine sustained-release tablet was successfully prepared, and the in vitro release was basically completed within 12 h, with accumulative release rate of 91.3% for anisodamine and 96.5% for neostigmine. CONCLUSIONS: Compound anisodamine and neostigmine sustained-release tablet that can cumulatively release for 12 h is successfully prepared.
期刊: 2017年第28卷第22期
作者: 李雨霏,周小莉,金拓
AUTHORS: LI Yufei,ZHOU Xiaoli,JIN Tuo
关键字: 山莨菪碱;新斯的明;复方缓释片;体外释药
KEYWORDS: Anisodamine; Neostigmine; Compound sustained-release tablet; in vitro drug-release
阅读数: 316 次
本月下载数: 5 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!